| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_661b3ea63e73acc96731eb73625b1bc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7d999bb6ab478a7ed29b45a75d9190d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-111 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-1101
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-54 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02 |
| filingDate |
2007-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3b507582300a3f776bba0e324c59c36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de9c7524bae859538b3a9ad07c66741c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95bd72ba79a0d9141a0355cacfca8d03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46e64f4a51f22377c9245fa715757067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e11d143d654d1d59885cad9424151c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f62dc542b83980ed71d058780069740
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_597b7e0c62c6ee5ba9c21eccfe30daab |
| publicationDate |
2007-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2653451-A1 |
| titleOfInvention |
Compositions and methods for inhibiting expression of ikk-b gene |
| abstract |
The invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of the IKK-B gene, comprising an antisense strand having a nucleotide sequence which is less that 30 nucleotides in length, generally 19-25 nucleotides in length, and which is substantially complementary to at least a part of the IKK-B gene. The invention also relates to a pharmaceutical composition comprising the dsRNA together with a pharmaceutically acceptable carrier; methods for treating diseases caused by the expression or activation of the IKK-B gene using the pharmaceutical composition; and methods for inhibiting the expression of the IKK-B gene in a cell. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113549639-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113549639-A |
| priorityDate |
2006-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |